Citadel Advisors’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,042,212
| Closed | -$29.1M | – | 7043 |
|
|
2023
Q4 | $29.1M | Buy |
2,042,212
+1,273,387
| +166% | +$18.1M | 0.01% | 688 |
|
|
2023
Q3 | $8.84M | Buy |
768,825
+41,803
| +6% | +$481K | ﹤0.01% | 1238 |
|
|
2023
Q2 | $12M | Buy |
727,022
+19,889
| +3% | +$327K | ﹤0.01% | 1094 |
|
|
2023
Q1 | $6.31M | Buy |
707,133
+702,770
| +16,107% | +$6.27M | ﹤0.01% | 1635 |
|
|
2022
Q4 | $9.9K | Sell |
4,363
-7,753
| -64% | -$17.6K | ﹤0.01% | 5687 |
|
|
2022
Q3 | $13K | Buy |
+12,116
| New | +$13K | ﹤0.01% | 5611 |
|